FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
IPO Status: Listed [1st Sep 2021 to 3rd Sep 2021]
Ami Organics, R&D driven specialty chemical manufacturer IPO opens for subscription on 1st Sep and closes on 3 Sep. It is a book-building IPO, face value is Rs. 10 per share, and the price band is fixed at Rs. 603-610. The minimum order quantity (no. of share) is 24 shares. Check out more details about the Ami Organics IPO including business overview, financials, issue size, important dates, lot size, strengths, weaknesses, etc.
IPO Issue Opening Date: | 1st Sep 2021 |
IPO Issue Closing Date: | 3rd Sep 2021 |
IPO Issue Price: | ₹603-610 Per Share |
DRHP: | Download DRHP |
RHP: | Download RHP |
Anchor List: | Download Anchor List |
IPO Listing At: | BSE, NSE |
Retail Quota: | 50.16 |
IPO Issue Type: | Book Build Issue |
IPO Issue Size: | ₹569.64 Cr |
Offer for Sale: | 6,059,600 shares at ₹603-610 each [Aggregating up to ₹369.64 Cr] |
Fresh Issue: | ₹200 Cr. |
Face Value: | ₹10 Per Equity Share |
IPO Discount: | NA |
Promoter Holding Pre IPO: | 47.23% |
Promoter Holding Post IPO: | 41.05% |
Allotment Status: | Allotment Status |
BSE Code: | 543349 |
NSE Code: | AMIORG |
Get important updates regarding Ami Organics IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
IPO Activity | Date |
---|---|
Basis of Allotment Date* | 8th Sep 2021 |
Refunds Initiation* | 9th Sep 2021 |
Credit of Shares to Demat* | 13th Sep 2021 |
IPO Listing Date* | 14th Sep 2021 |
* - Tentative Dates
IPO Activity | Date |
---|---|
Issue Price | ₹603-610 |
Market Lot: | 24 Shares |
1 Lot Amount: | ₹14640 |
Min Small HNI Lots(2-10 Lakh): | 336 shares(14 lots) |
Min Big HNI Lots(10+ Lakh): |
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Expected Listing Gain | Last Updated |
---|---|---|---|---|---|
14-09-2021 | 610 | 155 | -- | ₹765 (25.41%) | 14-Sep-2021 10:18 |
Zerodha Trade@20
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Ami Organics, one of the leading research & development-driven manufacturers of specialty chemicals. The company is engaged in the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients for new chemical entities. Recently, Ami Organics has acquired Gujarat Organics Limited (GOL) to manufacture starting materials for agrochemical and fine chemicals.
The Pharma intermediates manufactured by the company is used in high-growth therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed more than 450 Pharma intermediates across 17 diversified therapeutic areas. The firm not just supplies its products in the domestic market but also exports overseas such as China, Japan, Israel, the USA, Europe, and Latin America. Cadila Healthcare Limited and Cipla Limited are some of the renowned dometic customers and overseas customers include Organike s.r.l.a Socio Unico, Fermion Oy, Fabbrica Italiana Sintetici S.p.A, Chori Co. Ltd., Medichem S.A. and Midas Pharma GmbH.
Currently, the firm owns 3 manufacturing facilities at GIDC, Sachin, GIDC, Ankleshwar, and GIDC, Jhagadia with an total installed manufacturing capacity of 2460 MTPA, 1200 MTPA, and 2400 MTPA respectively.
Incorporation | Sector | IPO Issue Size | Website |
2004 | Specialty Chemicals | ₹569.64 Cr | http://www.amiorganics.com/ |
The table below is live update of IPO bidding details from NSE and BSE.
Day | QIB | NII | RII | Total | |
---|---|---|---|---|---|
# of Shares Offered | 1,854,166 (28.34%) | 1,406,453 (21.5%) | 3,281,723 (50.16%) | 6,542,342 | |
1 | 1st Sep 2021 17:02 | 1.39x | 0.40x | 2.82x | 1.90x |
2 | 2nd Sep 2021 17:02 | 1.43x | 1.51x | 6.32x | 3.90x |
3 | 3rd Sep 2021 17:02 | 86.64x | 154.81x | 13.36x | 64.54x |
Ami Organics Limited Financials | 31-Mar-2021 | 31-Mar-2020 | 31-Mar-2019 |
---|---|---|---|
Total Assets | ₹413.27 Cr | ₹231.89 Cr | ₹213.15 Cr |
Total Income | ₹341.99 Cr | ₹242.49 Cr | ₹238.90 Cr |
Net Profit/Loss | ₹54 Cr | ₹27.47 Cr | ₹23.29 Cr |
Last Updated on 27-Sep-2021 10:31:57